Kestra Medical Technologies (NASDAQ:KMTS) Hits New 12-Month Low - Time to Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $18.83 and last traded at $19.01, with a volume of 59723 shares trading hands. The stock had previously closed at $19.49.

Analysts Set New Price Targets

A number of analysts have recently issued reports on KMTS shares. Stifel Nicolaus started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $28.00 price target for the company. Piper Sandler assumed coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued an "overweight" rating and a $27.00 price objective for the company. Wells Fargo & Company started coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $28.00 target price on the stock. The Goldman Sachs Group lowered their target price on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 16th. Finally, Wolfe Research began coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price target for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Kestra Medical Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $27.50.

Kestra Medical Technologies Price Performance

The stock has a 50-day moving average price of $22.84.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last posted its quarterly earnings results on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter in the previous year, the business earned ($1.18) earnings per share.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP bought a new position in shares of Kestra Medical Technologies in the 1st quarter valued at about $33,000. Virtu Financial LLC acquired a new position in Kestra Medical Technologies during the first quarter valued at approximately $210,000. Armistice Capital LLC acquired a new stake in Kestra Medical Technologies in the first quarter valued at approximately $312,000. Zimmer Partners LP bought a new stake in shares of Kestra Medical Technologies during the first quarter worth about $374,000. Finally, Russell Investments Group Ltd. acquired a new position in Kestra Medical Technologies during the 1st quarter worth about $457,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.